Afya Ltd (AFYA)

Currency in USD
13.93
-0.46(-3.20%)
Closed·
13.930.00(0.00%)
·
Unusual trading volume
Trading near 52-week Low
AFYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.1213.99
52 wk Range
13.1219.90
Key Statistics
Prev. Close
14.39
Open
13.81
Day's Range
13.12-13.99
52 wk Range
13.12-19.9
Volume
349.27K
Average Volume (3m)
104.17K
1-Year Change
-11.4994%
Book Value / Share
9.82
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFYA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.09
Upside
+29.85%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Afya Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Afya Ltd Company Profile

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.

Afya Ltd Earnings Call Summary for Q3/2025

  • Afya exceeded Q3 2025 forecasts with EPS of $2.08 (18.18% above expectations) and revenue of $928.51 million, driving a 1.52% after-hours stock increase to $14.65.
  • Nine-month financial results showed strong growth: revenue up 13% to BRL 2,784M, adjusted EBITDA increased 19% to BRL 1,292M, and net income surged 20% to BRL 593M.
  • EBITDA margin expanded by 200 basis points to 46.4%, reflecting improved operational efficiency and successful strategic growth initiatives.
  • For 2026, Afya targets tuition increases of 5-5.2%, expects effective tax rate to converge to 15%, and plans to add approximately 200 new medical seats annually.
  • Management is exploring M&A opportunities in medical assets and considering capital allocation through buybacks and dividends to enhance shareholder value.
Last Updated: 2025-12-09, 03:12 a/m
Read Full Transcript

Compare AFYA to Peers and Sector

Metrics to compare
AFYA
Peers
Sector
Relationship
P/E Ratio
9.3x12.2x11.2x
PEG Ratio
0.370.360.02
Price/Book
1.4x1.9x1.4x
Price / LTM Sales
1.9x1.4x1.0x
Upside (Analyst Target)
25.9%34.2%21.7%
Fair Value Upside
Unlock25.6%9.2%Unlock

Analyst Ratings

3 Buy
4 Hold
2 Sell
Ratings:
9 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 18.09
(+29.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold16.00+14.86%18.00DowngradeJan 16, 2026
UBS
Buy18.00+29.22%19.00MaintainJan 08, 2026
JPMorgan
Hold22.00+57.93%24.50DowngradeJan 07, 2026
BofA Securities
Buy25.50+83.06%25.00MaintainSep 16, 2025
JPMorgan
Buy24.50+75.88%23.50UpgradeSep 08, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.99%
Dividend Yield
1.67%
Industry Median 1.06%
Annualized payout
0.23
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
2.08 / 1.76
Revenue / Forecast
928.51M / 924.61M
EPS Revisions
Last 90 days

AFYA Income Statement

People Also Watch

9.405
ENEI
+1.18%
3.718
NEXII
-1.69%
16.572
ENI
+0.78%
89.93
IPAR
-0.54%
37.160
AZMT
+0.35%

FAQ

What Is the Afya (AFYA) Stock Price Today?

The Afya stock price today is 13.93

What Stock Exchange Does Afya Trade On?

Afya is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Afya?

The stock symbol for Afya is "AFYA."

Does Afya Pay Dividends? What’s The Current Dividend Yield?

The Afya dividend yield is 1.67%.

What Is the Afya Market Cap?

As of today, Afya market cap is 1.26B.

What Is Afya's Earnings Per Share (TTM)?

The Afya EPS (TTM) is 7.99.

When Is the Next Afya Earnings Date?

Afya will release its next earnings report on Mar 27, 2026.

From a Technical Analysis Perspective, Is AFYA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Afya Stock Split?

Afya has split 0 times.

What is the current trading status of Afya (AFYA)?

As of Jan 18, 2026, Afya (AFYA) is trading at a price of 13.93, with a previous close of 14.39. The stock has fluctuated within a day range of 13.12 to 13.99, while its 52-week range spans from 13.12 to 19.90.

What Is Afya (AFYA) Price Target According to Analysts?

The average 12-month price target for Afya is USD18.08788137, with a high estimate of USD22.1721374 and a low estimate of USD15.7772846. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +29.85% Upside potential.

What Is the AFYA Premarket Price?

AFYA's last pre-market stock price is 14.12. The pre-market share volume is 290.00, and the stock has decreased by -0.27, or -1.88%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.